Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor
- 1 April 1995
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 345 (8956) , 1016-1020
- https://doi.org/10.1016/s0140-6736(95)90757-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- The Role of Idiotype-Specific, CD4+ T Cells in Tumor Resistance against Major Histocompatibility Complex Class II Molecule Negative Plasmacytoma CellsCellular Immunology, 1993
- LONG-TERM PERSISTENCE OF TRANSFERRED PPD-REACTIVE T CELLS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1993
- Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their TumorsNew England Journal of Medicine, 1992
- Studies on transfer of varicella-zoster-virus specific T-cell immunity from bone marrow donor to recipientBlood, 1990
- The transfer of antigen-specific humoral immunity from marrow donors to marrow recipientsJournal of Clinical Immunology, 1986
- TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROWThe Lancet, 1986
- A RAPID SCREENING TEST FOR ANTENATAL SEX DETERMINATIONThe Lancet, 1984
- Antibody to a molecularly-defined antigen confined to a tumour cell surfaceNature, 1975